Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
259
-
Total 13F shares, excl. options
-
10.8M
-
Shares change
-
+391K
-
Total reported value, excl. options
-
$2.4B
-
Value change
-
+$107M
-
Put/Call ratio
-
1.56
-
Number of buys
-
127
-
Number of sells
-
-133
-
Price
-
$221.55
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q3 2018
306 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q3 2018.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.8M shares
of 10.9M outstanding shares and own 99.22% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.69M shares), Vanguard Group Inc (1.29M shares), RENAISSANCE TECHNOLOGIES LLC (958K shares), DIMENSIONAL FUND ADVISORS LP (686K shares), ACADIAN ASSET MANAGEMENT LLC (426K shares), STATE STREET CORP (391K shares), GOLDMAN SACHS GROUP INC (253K shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (232K shares), Bank of New York Mellon Corp (191K shares), and PRINCIPAL FINANCIAL GROUP INC (176K shares).
This table shows the top 259 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.